
Influenza is a major public health concern that can cause infection in all age groups while leading to severe complications, hospitalization, and mortality particularly in the presence of risk factors such as advanced age, chronic comorbidities, immunosuppression and pregnancy. This multidisciplinary consensus report aimed to provide primary care physicians with a practical guidance document on adult influenza in terms of diagnosis, treatment, prevention of complications and vaccination through recommendations based on current scientific evidence for use in daily clinical practice. The report was prepared by a multidisciplinary expert panel involving family medicine, infectious diseases and clinical microbiology, internal medicine, endocrinology and cardiology academicians.
Objective: Individuals receiving home health care services often constitute a group with multiple chronic conditions, limited physical mobility, and restricted access to healthcare facilities. Immunization services are therefore critical for preventing infections in this population. Therefore, this study aimed to evaluate the frequency of pneumonia and related hospitalization rates after pneumococcal vaccination in patients receiving home healthcare services. Methods: A retrospective study was conducted at the Home Health Care Unit of Prof. Dr. Cemil Taşcıoğlu City Hospital, by reviewing the records of 125 patients who had received pneumococcal vaccination at home between June and September 2023. For each patient, the number of pneumonia episodes and hospitalization status before and after vaccination were compared. Results: A total of 125 patients were included in the study, consisting of 85 (68.0%) females and 40 (32.0%) males. Regarding age stratification, 9 (7.2%) patients were under 65 years of age, while 116 (92.8%) patients were 65 years of age and older. The mean number of pneumonia episodes decreased significantly from 1.68 ± 1.42 before vaccination to 0.44 ± 0.66 after vaccination, corresponding to an approximately 73.5% reduction (p < 0.001). After vaccination, patients had substantially lower odds of developing pneumonia (matched OR 12.40). A similar improvement was observed in hospitalization rates, which decreased from 17.6% before vaccination to 7.2% afterward (p = 0.019). Hospitalization odds were about threefold lower after vaccination. Conclusion: Our study shows that pneumococcal vaccination among home health care patients was associated with a significant reduction in pneumonia episodes and pneumonia-related hospitalizations. Given the uncontrolled pre–post design, these associations should not be interpreted as direct causal effects. The improvement observed after vaccination suggests that pneumococcal immunization is clinically important for high-risk individuals and should be expanded among similar risk groups. To maximize protection, healthcare providers should routinely screen the immunization status of home healthcare patients and integrate pneumococcal vaccination into standard homecare protocols as a priority preventie measure.
Objective: Although folate status has been widely studied, few studies have simultaneously evaluated multiple demographic, behavioral, and clinical factors in a single primary care population. This study aimed to determine the prevalence of folate insufficiency and evaluate the factors associated with this condition using routinely collected primary care data. Methods: This retrospective cross-sectional study used electronic health records from adults registered at the Uludağ University Family Health Center who underwent serum folate measurement between January 1, 2020, and December 31, 2024. All eligible individuals with complete data were included in the final analysis (n = 995). Statistical analyses were performed using IBM SPSS Statistics version 28.00. A two-sided p-value of <0.05 was considered statistically significant. Results: Of the 995 participants, 293 (29.4%) were male, and 702 (70.6%) were female; the mean age was 30.23 ± 12.92 years. Serum folate testing revealed insufficiency in 185 (18.6%) participants. In the multivariable model conducted among female participants, pregnancy complications (adjusted OR = 2.49, 95% CI: 1.34–3.60), allergic diseases (adjusted OR = 2.29, 95% CI: 1.19–3.31), genetic diseases (adjusted OR = 2.25, 95% CI: 1.29–3.54), cancer (adjusted OR = 1.81, 95% CI: 1.16–2.72), and non-pregnant status (adjusted OR = 1.70, 95% CI: 1.11–2.32) were independently associated with folate insufficiency. Conclusion: Pregnancy complications, allergic diseases, genetic diseases, and cancer were associated with higher odds of folate insufficiency, whereas pregnant participants had lower odds than non-pregnant participants. The association with pregnancy status should be interpreted cautiously because data on folic acid supplementation and antenatal follow-up were unavailable. Family physicians should consider targeted folate assessment in patients with pregnancy complications and in individuals with relevant inflammatory, genetic, or oncological conditions.
Objective: This study aimed to evaluate influenza and pneumococcal vaccination status and related factors among adults with obesity attending a single-center obesity outpatient clinic. Methods: This cross-sectional analytical study included 251 obese adults (BMI ≥30 kg/m2) who attended an obesity outpatient clinic. Data were collected using a structured face-to-face questionnaire including sociodemographic characteristics, body mass index, presence of chronic disease other than obesity, vaccination status, obesity-related risk perception, and sources of vaccine recommendation. Statistical analyses included Mann–Whitney U test, chi-square test, and multivariable logistic regression. Results: The study included 251 adults with obesity. The median age was 51 years, the median BMI was 35.7 kg/m2, 72.1% of participants were female, and 64.1% had chronic disease other than obesity. Influenza vaccination coverage was 45.8%, while pneumococcal vaccination coverage was 27.1%. Obesity-related risk perception was significantly associated with both influenza and pneumococcal vaccination uptake (p<0.001 for both). In multivariable analysis, absence of obesity-related risk perception was associated with lower odds of influenza vaccination (OR=0.03; 95% CI: 0.02–0.07; p<0.001), whereas the presence of chronic disease other than obesity increased the likelihood of influenza vaccination (OR=3.31; 95% CI: 1.58–6.95; p=0.002). For pneumococcal vaccination, older age increased the likelihood of vaccination (OR=1.06; 95% CI: 1.02–1.09; p<0.001), while absence of obesity-related risk perception was associated with lower vaccination uptake (OR=0.10; 95% CI: 0.04–0.23; p<0.001). Family physicians were the most frequently reported source of vaccine recommendation among vaccinated participants. Conclusion: These findings suggest that vaccination uptake among adults with obesity, particularly pneumococcal vaccination, may be improved by vaccine-specific counseling that emphasizes obesity-related infection risk, addresses safety concerns and information gaps, and supports clear vaccine recommendations during clinical encounters.